HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Kahn Selected Research

Ovarian Neoplasms (Ovarian Cancer)

1/2021The miR-181a-SFRP4 Axis Regulates Wnt Activation to Drive Stemness and Platinum Resistance in Ovarian Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Kahn Research Topics

Disease

28Neoplasms (Cancer)
01/2024 - 05/2005
8Fibrosis (Cirrhosis)
01/2024 - 08/2010
4Leukemia
01/2024 - 08/2011
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2024 - 02/2011
4Nasopharyngeal Carcinoma
06/2022 - 04/2015
4Inflammation (Inflammations)
01/2015 - 02/2002
4Colonic Neoplasms (Colon Cancer)
06/2014 - 08/2004
4Asthma (Bronchial Asthma)
11/2003 - 02/2002
3Disease Progression
01/2024 - 05/2009
3Pain (Aches)
01/2023 - 01/2020
3Neoplasm Metastasis (Metastasis)
06/2022 - 01/2011
3Breast Neoplasms (Breast Cancer)
01/2021 - 01/2011
3Carcinogenesis
03/2018 - 01/2014
3Wounds and Injuries (Trauma)
03/2017 - 04/2013
3Colorectal Neoplasms (Colorectal Cancer)
06/2014 - 05/2009
3Edema (Dropsy)
05/2005 - 02/2002
2Alzheimer Disease (Alzheimer's Disease)
01/2024 - 08/2005
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2024 - 09/2010
2Glioma (Gliomas)
01/2024 - 05/2015
2Pancreatic Neoplasms (Pancreatic Cancer)
11/2023 - 03/2018
2Liver Neoplasms (Liver Cancer)
01/2022 - 04/2013
2Hypoxia (Hypoxemia)
03/2017 - 11/2013
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2017 - 08/2011
2Hepatocellular Carcinoma (Hepatoma)
07/2014 - 04/2013
2Lung Injury
03/2013 - 01/2012
2Idiopathic Pulmonary Fibrosis
12/2012 - 01/2012
2Pulmonary Fibrosis (Fibrosing Alveolitis)
03/2012 - 08/2010
2Eosinophilia
11/2002 - 02/2002
1Prostatic Neoplasms (Prostate Cancer)
02/2024
1Glioblastoma (Glioblastoma Multiforme)
01/2024
1Chronic Renal Insufficiency
01/2024
1Cognitive Dysfunction
01/2024
1Hepatorenal form of glycogen storage disease
01/2024
1Acute Kidney Injury (Acute Renal Failure)
01/2024
1Squamous Cell Carcinoma of Head and Neck
11/2023
1Postoperative Pain
01/2023
1Non-alcoholic Fatty Liver Disease
01/2022
1Ovarian Neoplasms (Ovarian Cancer)
01/2021
1Tics (Tic)
01/2019
1Hematologic Neoplasms (Hematological Malignancy)
01/2019
1Triple Negative Breast Neoplasms
12/2018
1Adenocarcinoma
03/2018
1Hypoventilation
03/2017
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2016
1Parkinsonian Disorders (Parkinsonism)
05/2015

Drug/Important Bio-Agent (IBA)

34CateninsIBA
01/2024 - 02/2011
17ICG 001IBA
01/2024 - 08/2004
7beta CateninIBA
01/2024 - 08/2004
5SurvivinIBA
01/2024 - 05/2005
5Proteins (Proteins, Gene)FDA Link
11/2023 - 05/2005
4CollagenIBA
01/2024 - 09/2011
4TCF Transcription FactorsIBA
04/2013 - 08/2005
3CREB-Binding ProteinIBA
01/2024 - 08/2010
3MicroRNAs (MicroRNA)IBA
01/2019 - 12/2012
3Fibronectins (Fibronectin)IBA
11/2015 - 07/2011
3NF-kappa B (NF-kB)IBA
05/2005 - 11/2002
2Imatinib Mesylate (Gleevec)FDA Link
01/2024 - 01/2018
2Chimeric Antigen ReceptorsIBA
01/2024 - 01/2019
2Transcription Factors (Transcription Factor)IBA
01/2022 - 02/2003
2Estrogen ReceptorsIBA
01/2021 - 01/2011
2Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
03/2018 - 08/2010
2Carrier Proteins (Binding Protein)IBA
03/2018 - 08/2010
2LigandsIBA
01/2016 - 05/2009
2Bleomycin (Blenoxane)FDA LinkGeneric
01/2012 - 08/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2009 - 05/2005
2Transcription Factor AP-1 (Transcription Factor AP 1)IBA
02/2003 - 11/2002
2Interleukin-4 (Interleukin 4)IBA
02/2003 - 02/2002
2Interleukin-13IBA
11/2002 - 02/2002
1AndrogensIBA
02/2024
1Androgen Receptors (Androgen Receptor)IBA
02/2024
1Small Cytoplasmic RNAIBA
01/2024
1EnzymesIBA
01/2024
1AntigensIBA
01/2024
1GlycogenIBA
01/2024
1Extracellular Matrix ProteinsIBA
01/2024
1Cytostatic AgentsIBA
01/2024
1ReninIBA
01/2024
1ProdrugsIBA
01/2024
1Insulin (Novolin)FDA Link
11/2023
1ChromatinIBA
11/2023
1Opioid Analgesics (Opioids)IBA
01/2023
1Anesthetics (Anesthetic Agents)IBA
01/2021
1PlatinumIBA
01/2021
1Messenger RNA (mRNA)IBA
01/2019
1GemcitabineFDA Link
03/2018
1Tyrosine Kinase InhibitorsIBA
01/2018
1NexusIBA
01/2017
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
05/2015
1Cisplatin (Platino)FDA LinkGeneric
04/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2015

Therapy/Procedure

15Therapeutics
02/2024 - 09/2010
4Drug Therapy (Chemotherapy)
01/2024 - 08/2011
2Immunotherapy
01/2024 - 01/2019
2Pain Management
01/2023 - 01/2020
1Castration
02/2024
1Decompression
01/2024
1Aftercare (After-Treatment)
01/2024
1Organ Transplantation
01/2023
1Laryngoscopes
03/2017
1Airway Management
03/2017